Sign in
4

Changes in Ownership

RESMED INC Filed Acc 0001127602-25-015607

Chief Financial Officer sold 3,644 shares at $244.59 ($891,286)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Sandercock Brett Chief Financial Officer 2025-05-22 Sale 10b5-1 −3,644 $244.59 $891,286 86,283 D: show line 1 in the form
Open-market sales · 3,644 sh · avg $244.59 · $891,286
Loading xslF345X05/form4.xml…